CDNA · NASDAQ
CareDx (CDNA) Stock Price & Fundamentals
CareDx (CDNA) closed at $454.27 on Oct 9, 2026, down 0.74% from the previous close of $457.66.
Share price, past year
1Y +13.10%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $454.27 |
| Sep 30, 2026 | $457.81 |
| Aug 31, 2026 | $445.64 |
| Jul 31, 2026 | $451.23 |
| Jun 30, 2026 | $444.66 |
| May 29, 2026 | $414.48 |
| Apr 30, 2026 | $408.17 |
| Mar 31, 2026 | $403.04 |
| Feb 27, 2026 | $385.48 |
| Jan 30, 2026 | $388.14 |
| Dec 31, 2025 | $390.76 |
| Nov 28, 2025 | $395.65 |
| Oct 31, 2025 | $407.67 |
Key statistics
- Market cap
- $23.39B
- P/E (TTM)
- 219.5
- EPS (TTM)
- $2.07
- Revenue (TTM)
- $458.09M
- Net income (TTM)
- $111.01M
- Shares outstanding
- 51.5M
- Dividend yield
- —
- 52-week range
- $379.69 – $470.60
CareDx's market cap is $23.39B, based on a share price of $454.27 and 51.5M shares outstanding as of Jun 30, 2026.
Financials
CareDx reported revenue of $379.81M for fiscal 2025, up 13.79% from fiscal 2024.
CareDx reported a net loss of $21.35M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $379.81M | +13.8% | −$21.35M | −5.6% | −$0.40 | — |
| FY2024ended Dec 31, 2024 | $333.79M | +19.1% | $52.55M | 15.7% | $0.93 | — |
| FY2023ended Dec 31, 2023 | $280.32M | −12.9% | −$190.28M | −67.9% | −$3.54 | — |
| FY2022ended Dec 31, 2022 | $321.79M | +8.6% | −$76.61M | −23.8% | −$1.44 | — |
| FY2021ended Dec 31, 2021 | $296.40M | +54.2% | −$30.66M | −10.3% | −$0.59 | — |
| FY2020ended Dec 31, 2020 | $192.19M | +51.3% | −$18.71M | −9.7% | −$0.40 | — |
| FY2019ended Dec 31, 2019 | $127.07M | +66.0% | −$21.97M | −17.3% | −$0.52 | — |
| FY2018ended Dec 31, 2018 | $76.57M | +58.5% | −$46.76M | −61.1% | −$1.31 | −$6.04M |
| FY2017ended Dec 31, 2017 | $48.32M | +18.9% | −$55.47M | −114.8% | −$2.38 | −$14.49M |
| FY2016ended Dec 31, 2016 | $40.63M | — | −$39.47M | −97.1% | −$2.39 | −$17.07M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $131.95M | $110.64M | $2.07 |
| Q1 FY2026ended Mar 31, 2026 | $117.70M | $2.81M | $0.05 |
| Q4 FY2025ended Dec 31, 2025 | $108.39M | −$4.11M | −$0.08 |
| Q3 FY2025ended Sep 30, 2025 | $100.06M | $1.68M | $0.03 |
| Q2 FY2025ended Jun 30, 2025 | $86.68M | −$8.57M | −$0.16 |
| Q1 FY2025ended Mar 31, 2025 | $84.69M | −$10.35M | −$0.19 |
| Q4 FY2024ended Dec 31, 2024 | $86.58M | $87.70M | $1.60 |
| Q3 FY2024ended Sep 30, 2024 | $82.88M | −$10.64M | −$0.20 |
Company profile
- Name
- CareDx, Inc.
- Ticker
- CDNA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Medical Laboratories
- Headquarters
- 8000 Marina Blvd, 4th Floor, Brisbane, CA 94005
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001217234
Recent SEC filings
- Jul 30, 2026
- Jul 30, 2026
- Jul 7, 2026
- Jun 15, 2026
- Apr 28, 2026
- Apr 28, 2026
- Apr 16, 2026
- Feb 25, 2026
Frequently asked questions
What is CareDx's stock price?
CareDx (CDNA) closed at $454.27 on Oct 9, 2026, down 0.74% from the previous close of $457.66.
What is CareDx's market cap?
CareDx's market cap is $23.39B, based on a share price of $454.27 and 51.5M shares outstanding as of Jun 30, 2026.
How much revenue does CareDx make?
CareDx reported revenue of $379.81M for fiscal 2025, up 13.79% from fiscal 2024.
What is CDNA's P/E ratio?
CareDx's price-to-earnings ratio is 219.5, based on trailing twelve-month diluted EPS of $2.07.
Does CareDx pay a dividend?
CareDx's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from CareDx, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures